Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 9:59 PM ET

Healthcare Equipment and Supplies

Company Overview of Solta Medical, Inc.

Company Overview

Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system, a treatment to improve skin texture and help prevent the signs of aging skin. The company also provides Thermage CPT system that provides non-invasive treatment options...

25881 Industrial Boulevard

Hayward, CA 94545

United States

Founded in 1996

371 Employees





Key Executives for Solta Medical, Inc.

Chief Executive Officer, President and Director
Age: 56
Corporate Controller
Age: 51
Treasurer and Director
Age: 53
Secretary and Director
Age: 45
Compensation as of Fiscal Year 2015.

Solta Medical, Inc. Key Developments

Solta Medical, Inc. Launches Clear + Brilliant Pelo Laser

Solta Medical, Inc. announced the availability of the Clear + Brilliant pelo laser in the United States, a sophisticated approach to permanent hair reduction. The launch of this device, which joins the comprehensive portfolio of Solta Medical's aesthetic device solutions, follows a unique partnership with German Medical Engineering. The Clear + Brilliant pelo laser system uses a novel linear scanning approach with integrated contact cooling to deliver the effectiveness of current best-in-class diode laser hair removal technology with the fast and large treatment area available (50 mm by 15 mm). In addition, a unique all-inclusive subscription model will provide ease-of-mind and simplicity in ensuring consistent device performance and dependable support. Clear + Brilliant pelo will first be made exclusively available to current Solta Medical customers in the U.S, with full release scheduled in the fourth quarter of 2015.

Solta Medical, Inc. Announces Amendment and Restatement of Certificate of Incorporation

Solta Medical, Inc. amended and restated Certificate of Incorporation was amended and restated and the company's Amended and Restated Bylaws were amended and restated.

Solta Medical, Inc. Announces Management Changes

Pursuant to the terms of the Merger Agreement, on December 15, 2013, Solta Medical, Inc. entered into an Agreement and plan of merger with Valeant Pharmaceuticals International, Sapphire Subsidiary Corp. (the “Purchaser”), at the Effective Time, the directors and officers of the Purchaser immediately prior to the Effective Time became the directors and officers of Solta following the Effective Time. Accordingly, at the Effective Time, each of Mark M. Sieczkarek, Cathy L. McCarthy, David Holthe, Eric B. Stang, Harold Covert and Linda Graebner resigned as directors of Solta and any committee thereof. Each director resigned in accordance with the Merger Agreement, and no director resigned because of any disagreement with the Company on any matter relating to Solta’s operation, policies, or practices. Also at the Effective Time, Mr. Mark M. Sieczkarek, the Interim President and Chief Executive Officer, Mr. Jack Glenn, the Chief Financial Officer, Mr. H. Daniel Ferrari, Vice President of Finance, Mr. Doug W. Heigel, Vice President of Operations, Mr. Jeff Nardoci, Vice President of Worldwide Marketing, General Manager Surgical Specialties, and Dr. Lisa Parr, Vice President, Regulatory Affairs and Clinical Affairs, ceased being executive officers of Solta. At the Effective Time, Mr. J. Michael Pearson assumed the role of director, President and Chief Executive Officer of Solta, Mr. Howard B. Schiller assumed the role of director and Treasurer of Solta and Mr. Robert Chai-Onn assumed the role of director and Secretary of Solta. At the time Messrs. Schiller, Chai-Onn and Pearson assumed the roles of directors, it had not yet been determined on which committees, if any, of the Board of Directors of Solta Messrs. Schiller, Chai-Onn and Pearson would serve.

Similar Private Companies By Industry

Company Name Region
Heartview, LLC United States
Zonda Incorporated United States
Larada Sciences, Inc. United States
Interrad Medical, Inc. United States
Aptus Endosystems, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Solta Medical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at